공황장애 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "공황장애" in Korean language version.

refsWebsite

Global rank Korean rank

29nih.gov

4^th place

22doi.org

2^nd place

3^rd place

6archive.org

6^th place

18^th place

6semanticscholar.org

11^th place

310^th place

4web.archive.org

1^st place

2books.google.com

3^rd place

9^th place

1snu.ac.kr

low place

179^th place

1medscape.com

719^th place

424^th place

1ama-assn.org

3,257^th place

2,201^st place

1psychiatrictimes.com

9,815^th place

9,489^th place

1psu.edu

207^th place

220^th place

1gsa.gov

low place

1handle.net

102^nd place

307^th place

1qucosa.de

low place

1nice.org.uk

3,258^th place

1,025^th place

1revmed.ch

low place

1psychiatryonline.com

low place

1worldcat.org

5^th place

11^th place

ama-assn.org

jama.ama-assn.org

Barlow DH, Gorman JM, Shear MK, Woods SW (May 2000). “Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial”. 《JAMA》 283 (19): 2529–36. doi:10.1001/jama.283.19.2529. PMID 10815116.

archive.org

Rathgeb-Fuetsch M, Kempter G, Feil A, Pollmächer T, Schuld A (September 2011). “Short- and long- term efficacy of cognitive behavioral therapy for DSM-IV panic disorder in patients with and without severe psychiatric comorbidity”. 《Journal of Psychiatric Research》 45 (9): 1264–8. doi:10.1016/j.jpsychires.2011.03.018. PMID 21536308.
Schmidt, Norman B.; Woolaway-Bickel, Kelly; Trakowski, Jack; Santiago, Helen; Storey, Julie; Koselka, Margaret; Cook, Jeff (2000). “Dismantling cognitive–behavioral treatment for panic disorder: Questioning the utility of breathing retraining.”. 《Journal of Consulting and Clinical Psychology》 68 (3): 417–424. CiteSeerX 10.1.1.561.9948. doi:10.1037//0022-006x.68.3.417. PMID 10883558.
Gloster, Andrew T.; Wittchen, Hans-Ulrich; Einsle, Franziska; Lang, Thomas; Helbig-Lang, Sylvia; Fydrich, Thomas; Fehm, Lydia; Hamm, Alfons O.; Richter, Jan; Alpers, Georg W.; Gerlach, Alexander L.; Ströhle, Andreas; Kircher, Tilo; Deckert, Jürgen; Zwanzger, Peter; Höfler, Michael; Arolt, Volker (2011). “Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.”. 《Journal of Consulting and Clinical Psychology》 79 (3): 406–420. doi:10.1037/a0023584. PMID 21534651.
Koszycki, D.; Taljaard, M.; Segal, Z.; Bradwejn, J. (February 2011). “A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder”. 《Psychological Medicine》 41 (2): 373–383. doi:10.1017/S0033291710000930. PMID 20462466. S2CID 36613894.
Nolen-Hoeksema, Susan (2014년 1월 1일). 《Abnormal Psychology》. McGraw-Hill Education – Europe. ISBN 978-1-259-06072-4.
Bruce MS, Lader M (February 1989). “Caffeine abstention in the management of anxiety disorders”. 《Psychological Medicine》 19 (1): 211–4. doi:10.1017/S003329170001117X. PMID 2727208.

books.google.com

Prasad, Chandan (2005). 《Nutritional Neuroscience》. CRC Press. 351쪽. ISBN 978-0415315999. 2012년 10월 7일에 확인함.
Nehlig, Astrid (2004). 《Coffee, Tea, Chocolate, and the Brain》. CRC Press. 136쪽. ISBN 978-0415306911. 2012년 10월 7일에 확인함.

doi.org

dx.doi.org

Salvador-Carulla L, Seguí J, Fernández-Cano P, Canet J (April 1995). “Costs and offset effect in panic disorders”. 《The British Journal of Psychiatry. Supplement》 166 (27): 23–8. doi:10.1192/S0007125000293367. PMID 7794590.
Rathgeb-Fuetsch M, Kempter G, Feil A, Pollmächer T, Schuld A (September 2011). “Short- and long- term efficacy of cognitive behavioral therapy for DSM-IV panic disorder in patients with and without severe psychiatric comorbidity”. 《Journal of Psychiatric Research》 45 (9): 1264–8. doi:10.1016/j.jpsychires.2011.03.018. PMID 21536308.
Marks, Isaac M.; Swinson, Richard P.; Başoǧlu, Metin; Kuch, Klaus; Noshirvani, Homa; O'Sullivan, Geraldine; Lelliott, Paul T.; Kirby, Marlene; McNamee, Gary; Sengun, Seda; Wickwire, Kim (June 1993). “Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto”. 《British Journal of Psychiatry》 162 (6): 776–787. doi:10.1192/bjp.162.6.776. PMID 8101126. S2CID 25233822.
Milrod BL, Leon AC, Barber JP, Markowitz JC, Graf E (June 2007). “Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline”. 《The Journal of Clinical Psychiatry》 68 (6): 885–91. doi:10.4088/JCP.v68n0610. PMID 17592913.
Barlow DH, Gorman JM, Shear MK, Woods SW (May 2000). “Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial”. 《JAMA》 283 (19): 2529–36. doi:10.1001/jama.283.19.2529. PMID 10815116.
Watanabe, Norio; Churchill, Rachel; Furukawa, Toshi A (2009년 1월 21일). “Combined psychotherapy plus benzodiazepines for panic disorder”. 《Cochrane Database of Systematic Reviews》 (1): CD005335. doi:10.1002/14651858.CD005335.pub2. PMID 19160253.
Schmidt, Norman B.; Woolaway-Bickel, Kelly; Trakowski, Jack; Santiago, Helen; Storey, Julie; Koselka, Margaret; Cook, Jeff (2000). “Dismantling cognitive–behavioral treatment for panic disorder: Questioning the utility of breathing retraining.”. 《Journal of Consulting and Clinical Psychology》 68 (3): 417–424. CiteSeerX 10.1.1.561.9948. doi:10.1037//0022-006x.68.3.417. PMID 10883558.
van Apeldoorn, F. J.; van Hout, W. J. P. J.; Mersch, P. P. A.; Huisman, M.; Slaap, B. R.; Hale, W. W.; Visser, S.; van Dyck, R.; den Boer, J. A. (April 2008). “Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia”. 《Acta Psychiatrica Scandinavica》 117 (4): 260–270. doi:10.1111/j.1600-0447.2008.01157.x. hdl:1874/385414. PMID 18307586. S2CID 23376651.
Gloster, Andrew T.; Wittchen, Hans-Ulrich; Einsle, Franziska; Lang, Thomas; Helbig-Lang, Sylvia; Fydrich, Thomas; Fehm, Lydia; Hamm, Alfons O.; Richter, Jan; Alpers, Georg W.; Gerlach, Alexander L.; Ströhle, Andreas; Kircher, Tilo; Deckert, Jürgen; Zwanzger, Peter; Höfler, Michael; Arolt, Volker (2011). “Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.”. 《Journal of Consulting and Clinical Psychology》 79 (3): 406–420. doi:10.1037/a0023584. PMID 21534651.
Koszycki, D.; Taljaard, M.; Segal, Z.; Bradwejn, J. (February 2011). “A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder”. 《Psychological Medicine》 41 (2): 373–383. doi:10.1017/S0033291710000930. PMID 20462466. S2CID 36613894.
Barlow, David H.; Gorman, Jack M.; Shear, M. Katherine; Woods, Scott W. (2000년 5월 17일). “Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial”. 《JAMA》 283 (19): 2529–36. doi:10.1001/jama.283.19.2529. PMID 10815116.
Wiborg, Ida M.; Dahl, AA (1996년 8월 1일). “Does Brief Dynamic Psychotherapy Reduce the Relapse Rate of Panic Disorder?”. 《Archives of General Psychiatry》 53 (8): 689–94. doi:10.1001/archpsyc.1996.01830080041008. PMID 8694682.
Lewis, Catrin; Pearce, Jennifer; Bisson, Jonathan I. (January 2012). “Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review”. 《British Journal of Psychiatry》 200 (1): 15–21. doi:10.1192/bjp.bp.110.084756. PMID 22215865.
Lewis, Catrin; Pearce, Jennifer; Bisson, Jonathan I. (January 2012). “Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review”. 《British Journal of Psychiatry》 200 (1): 15–21. doi:10.1192/bjp.bp.110.084756. PMID 22215865.
Khalsa, Sahib S.; Lapidus, Rachel C. (2016). “Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?”. 《Frontiers in Psychiatry》 7: 121. doi:10.3389/fpsyt.2016.00121. PMC 4958623. PMID 27504098.
Moylan, Steven; Giorlando, Francesco; Nordfjærn, Trond; Berk, Michael (March 2012). “The role of alprazolam for the treatment of panic disorder in Australia”. 《Australian & New Zealand Journal of Psychiatry》 46 (3): 212–224. doi:10.1177/0004867411432074. PMID 22391278. S2CID 11006795.
Goodwin, R.D.; Faravelli, C.; Rosi, S.; Cosci, F.; Truglia, E.; de Graaf, R.; Wittchen, H.U. (August 2005). “The epidemiology of panic disorder and agoraphobia in Europe”. 《European Neuropsychopharmacology》 15 (4): 435–443. doi:10.1016/j.euroneuro.2005.04.006. PMID 15925492. S2CID 14905286.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (October 2002). “World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders”. 《The World Journal of Biological Psychiatry》 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, Keller MB (August 2003). “Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?”. 《The American Journal of Psychiatry》 160 (8): 1432–8. doi:10.1176/appi.ajp.160.8.1432. PMID 12900305.
Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, 외. (March 2019). “Benzodiazepines versus placebo for panic disorder in adults”. 《The Cochrane Database of Systematic Reviews》 3: CD010677. doi:10.1002/14651858.CD010677.pub2. PMC 6438660. PMID 30921478.
Bruce MS, Lader M (February 1989). “Caffeine abstention in the management of anxiety disorders”. 《Psychological Medicine》 19 (1): 211–4. doi:10.1017/S003329170001117X. PMID 2727208.
Juliano, Laura M.; Griffiths, Roland R. (2004년 10월 1일). “A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features”. 《Psychopharmacology》 176 (1): 1–29. doi:10.1007/s00213-004-2000-x. PMID 15448977. S2CID 5572188.

gsa.gov

pueblo.gsa.gov

“Panic Disorder”. National Institute of Mental Health. 2006년 4월 28일에 원본 문서에서 보존된 문서. 2006년 5월 12일에 확인함.

handle.net

hdl.handle.net

van Apeldoorn, F. J.; van Hout, W. J. P. J.; Mersch, P. P. A.; Huisman, M.; Slaap, B. R.; Hale, W. W.; Visser, S.; van Dyck, R.; den Boer, J. A. (April 2008). “Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia”. 《Acta Psychiatrica Scandinavica》 117 (4): 260–270. doi:10.1111/j.1600-0447.2008.01157.x. hdl:1874/385414. PMID 18307586. S2CID 23376651.

medscape.com

Cloos JM (January 2005). “The treatment of panic disorder”. 《Current Opinion in Psychiatry》 18 (1): 45–50. PMID 16639183. 4 April 2011에 원본 문서에서 보존된 문서.

nice.org.uk

“Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder” (PDF). National Collaborating Centre for Primary Care. 2004. 19 February 2009에 원본 문서 (PDF)에서 보존된 문서. 16 June 2009에 확인함.

nih.gov

ncbi.nlm.nih.gov

Salvador-Carulla L, Seguí J, Fernández-Cano P, Canet J (April 1995). “Costs and offset effect in panic disorders”. 《The British Journal of Psychiatry. Supplement》 166 (27): 23–8. doi:10.1192/S0007125000293367. PMID 7794590.
Cloos JM (January 2005). “The treatment of panic disorder”. 《Current Opinion in Psychiatry》 18 (1): 45–50. PMID 16639183. 4 April 2011에 원본 문서에서 보존된 문서.
Foldes-Busque G, Marchand A, Landry P (October 2007). “[Early detection and treatment of panic disorder with or without agoraphobia: update]”. 《Canadian Family Physician》 53 (10): 1686–93. PMC 2231433. PMID 17934032.
Rathgeb-Fuetsch M, Kempter G, Feil A, Pollmächer T, Schuld A (September 2011). “Short- and long- term efficacy of cognitive behavioral therapy for DSM-IV panic disorder in patients with and without severe psychiatric comorbidity”. 《Journal of Psychiatric Research》 45 (9): 1264–8. doi:10.1016/j.jpsychires.2011.03.018. PMID 21536308.
Marks, Isaac M.; Swinson, Richard P.; Başoǧlu, Metin; Kuch, Klaus; Noshirvani, Homa; O'Sullivan, Geraldine; Lelliott, Paul T.; Kirby, Marlene; McNamee, Gary; Sengun, Seda; Wickwire, Kim (June 1993). “Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto”. 《British Journal of Psychiatry》 162 (6): 776–787. doi:10.1192/bjp.162.6.776. PMID 8101126. S2CID 25233822.
Milrod BL, Leon AC, Barber JP, Markowitz JC, Graf E (June 2007). “Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline”. 《The Journal of Clinical Psychiatry》 68 (6): 885–91. doi:10.4088/JCP.v68n0610. PMID 17592913.
Barlow DH, Gorman JM, Shear MK, Woods SW (May 2000). “Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial”. 《JAMA》 283 (19): 2529–36. doi:10.1001/jama.283.19.2529. PMID 10815116.
Watanabe, Norio; Churchill, Rachel; Furukawa, Toshi A (2009년 1월 21일). “Combined psychotherapy plus benzodiazepines for panic disorder”. 《Cochrane Database of Systematic Reviews》 (1): CD005335. doi:10.1002/14651858.CD005335.pub2. PMID 19160253.
Schmidt, Norman B.; Woolaway-Bickel, Kelly; Trakowski, Jack; Santiago, Helen; Storey, Julie; Koselka, Margaret; Cook, Jeff (2000). “Dismantling cognitive–behavioral treatment for panic disorder: Questioning the utility of breathing retraining.”. 《Journal of Consulting and Clinical Psychology》 68 (3): 417–424. CiteSeerX 10.1.1.561.9948. doi:10.1037//0022-006x.68.3.417. PMID 10883558.
van Apeldoorn, F. J.; van Hout, W. J. P. J.; Mersch, P. P. A.; Huisman, M.; Slaap, B. R.; Hale, W. W.; Visser, S.; van Dyck, R.; den Boer, J. A. (April 2008). “Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia”. 《Acta Psychiatrica Scandinavica》 117 (4): 260–270. doi:10.1111/j.1600-0447.2008.01157.x. hdl:1874/385414. PMID 18307586. S2CID 23376651.
Gloster, Andrew T.; Wittchen, Hans-Ulrich; Einsle, Franziska; Lang, Thomas; Helbig-Lang, Sylvia; Fydrich, Thomas; Fehm, Lydia; Hamm, Alfons O.; Richter, Jan; Alpers, Georg W.; Gerlach, Alexander L.; Ströhle, Andreas; Kircher, Tilo; Deckert, Jürgen; Zwanzger, Peter; Höfler, Michael; Arolt, Volker (2011). “Psychological treatment for panic disorder with agoraphobia: A randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.”. 《Journal of Consulting and Clinical Psychology》 79 (3): 406–420. doi:10.1037/a0023584. PMID 21534651.
Koszycki, D.; Taljaard, M.; Segal, Z.; Bradwejn, J. (February 2011). “A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder”. 《Psychological Medicine》 41 (2): 373–383. doi:10.1017/S0033291710000930. PMID 20462466. S2CID 36613894.
Seguí J, Márquez M, Canet J, García L (1999). “Causas de fracaso en el tratamiento psicofarmacologico del trastorno por angustia” [Causes of failure in psychopharmacological treatment of anxiety disorder]. 《Actas Espanolas de Psiquiatria》 (스페인어) 27 (4): 250–258. PMID 10469946.
Barlow, David H.; Gorman, Jack M.; Shear, M. Katherine; Woods, Scott W. (2000년 5월 17일). “Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial”. 《JAMA》 283 (19): 2529–36. doi:10.1001/jama.283.19.2529. PMID 10815116.
Wiborg, Ida M.; Dahl, AA (1996년 8월 1일). “Does Brief Dynamic Psychotherapy Reduce the Relapse Rate of Panic Disorder?”. 《Archives of General Psychiatry》 53 (8): 689–94. doi:10.1001/archpsyc.1996.01830080041008. PMID 8694682.
Lewis, Catrin; Pearce, Jennifer; Bisson, Jonathan I. (January 2012). “Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review”. 《British Journal of Psychiatry》 200 (1): 15–21. doi:10.1192/bjp.bp.110.084756. PMID 22215865.
Lewis, Catrin; Pearce, Jennifer; Bisson, Jonathan I. (January 2012). “Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review”. 《British Journal of Psychiatry》 200 (1): 15–21. doi:10.1192/bjp.bp.110.084756. PMID 22215865.
Khalsa, Sahib S.; Lapidus, Rachel C. (2016). “Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?”. 《Frontiers in Psychiatry》 7: 121. doi:10.3389/fpsyt.2016.00121. PMC 4958623. PMID 27504098.
Moylan, Steven; Giorlando, Francesco; Nordfjærn, Trond; Berk, Michael (March 2012). “The role of alprazolam for the treatment of panic disorder in Australia”. 《Australian & New Zealand Journal of Psychiatry》 46 (3): 212–224. doi:10.1177/0004867411432074. PMID 22391278. S2CID 11006795.
Goodwin, R.D.; Faravelli, C.; Rosi, S.; Cosci, F.; Truglia, E.; de Graaf, R.; Wittchen, H.U. (August 2005). “The epidemiology of panic disorder and agoraphobia in Europe”. 《European Neuropsychopharmacology》 15 (4): 435–443. doi:10.1016/j.euroneuro.2005.04.006. PMID 15925492. S2CID 14905286.
Damsa, Cristian; Lazignac, Coralie; Iancu, Ruxandra; Niquille, Marc; Miller, Nick; Mihai, Adriana; Virgillito, Salvatore; Adam, Eric (2008). “Troubles paniques : du diagnostic différentiel vers une prise en charge urgente” [Panic disorders: differential diagnosis and care in emergencies]. 《Revue Médicale Suisse》 (프랑스어) 4 (144): 404–409. PMID 18320769.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ (October 2002). “World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders”. 《The World Journal of Biological Psychiatry》 3 (4): 171–99. doi:10.3109/15622970209150621. PMID 12516310.
Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, Keller MB (August 2003). “Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?”. 《The American Journal of Psychiatry》 160 (8): 1432–8. doi:10.1176/appi.ajp.160.8.1432. PMID 12900305.
Stevens JC, Pollack MH (2005). “Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents”. 《The Journal of Clinical Psychiatry》. 66. 66 Suppl 2: 21–7. PMID 15762816.
School Of Health Related Research (Scharr), University of Sheffield (2004). 《Clinical Guidelines for the Management of Anxiety: Management of Anxiety》. National Institute for Health and Clinical Excellence: Guidance. National Collaborating Centre for Primary Care. OCLC 708544131. PMID 20945576.
Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, 외. (March 2019). “Benzodiazepines versus placebo for panic disorder in adults”. 《The Cochrane Database of Systematic Reviews》 3: CD010677. doi:10.1002/14651858.CD010677.pub2. PMC 6438660. PMID 30921478.
Bruce MS, Lader M (February 1989). “Caffeine abstention in the management of anxiety disorders”. 《Psychological Medicine》 19 (1): 211–4. doi:10.1017/S003329170001117X. PMID 2727208.
Juliano, Laura M.; Griffiths, Roland R. (2004년 10월 1일). “A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features”. 《Psychopharmacology》 176 (1): 1–29. doi:10.1007/s00213-004-2000-x. PMID 15448977. S2CID 5572188.

nimh.nih.gov

“Anxiety Disorders”. 《NIMH》. March 2016. 29 September 2016에 원본 문서에서 보존된 문서. 1 October 2016에 확인함.

psu.edu

citeseerx.ist.psu.edu

Schmidt, Norman B.; Woolaway-Bickel, Kelly; Trakowski, Jack; Santiago, Helen; Storey, Julie; Koselka, Margaret; Cook, Jeff (2000). “Dismantling cognitive–behavioral treatment for panic disorder: Questioning the utility of breathing retraining.”. 《Journal of Consulting and Clinical Psychology》 68 (3): 417–424. CiteSeerX 10.1.1.561.9948. doi:10.1037//0022-006x.68.3.417. PMID 10883558.

psychiatrictimes.com

Busch, Fredric N.; Milrod, Barbara L. (2008년 2월 1일). “Panic-Focused Psychodynamic Psychotherapy”. 《Psychiatric Times》 25 (2).

psychiatryonline.com

Work Group on Panic Disorder (January 2009). “APA Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition” (PDF). 2009년 7월 12일에 확인함.

qucosa.de

tud.qucosa.de

Goodwin, R.D.; Faravelli, C.; Rosi, S.; Cosci, F.; Truglia, E.; de Graaf, R.; Wittchen, H.U. (August 2005). “The epidemiology of panic disorder and agoraphobia in Europe”. 《European Neuropsychopharmacology》 15 (4): 435–443. doi:10.1016/j.euroneuro.2005.04.006. PMID 15925492. S2CID 14905286.

revmed.ch

Damsa, Cristian; Lazignac, Coralie; Iancu, Ruxandra; Niquille, Marc; Miller, Nick; Mihai, Adriana; Virgillito, Salvatore; Adam, Eric (2008). “Troubles paniques : du diagnostic différentiel vers une prise en charge urgente” [Panic disorders: differential diagnosis and care in emergencies]. 《Revue Médicale Suisse》 (프랑스어) 4 (144): 404–409. PMID 18320769.

semanticscholar.org

api.semanticscholar.org

Marks, Isaac M.; Swinson, Richard P.; Başoǧlu, Metin; Kuch, Klaus; Noshirvani, Homa; O'Sullivan, Geraldine; Lelliott, Paul T.; Kirby, Marlene; McNamee, Gary; Sengun, Seda; Wickwire, Kim (June 1993). “Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto”. 《British Journal of Psychiatry》 162 (6): 776–787. doi:10.1192/bjp.162.6.776. PMID 8101126. S2CID 25233822.
van Apeldoorn, F. J.; van Hout, W. J. P. J.; Mersch, P. P. A.; Huisman, M.; Slaap, B. R.; Hale, W. W.; Visser, S.; van Dyck, R.; den Boer, J. A. (April 2008). “Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia”. 《Acta Psychiatrica Scandinavica》 117 (4): 260–270. doi:10.1111/j.1600-0447.2008.01157.x. hdl:1874/385414. PMID 18307586. S2CID 23376651.
Koszycki, D.; Taljaard, M.; Segal, Z.; Bradwejn, J. (February 2011). “A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder”. 《Psychological Medicine》 41 (2): 373–383. doi:10.1017/S0033291710000930. PMID 20462466. S2CID 36613894.
Moylan, Steven; Giorlando, Francesco; Nordfjærn, Trond; Berk, Michael (March 2012). “The role of alprazolam for the treatment of panic disorder in Australia”. 《Australian & New Zealand Journal of Psychiatry》 46 (3): 212–224. doi:10.1177/0004867411432074. PMID 22391278. S2CID 11006795.
Goodwin, R.D.; Faravelli, C.; Rosi, S.; Cosci, F.; Truglia, E.; de Graaf, R.; Wittchen, H.U. (August 2005). “The epidemiology of panic disorder and agoraphobia in Europe”. 《European Neuropsychopharmacology》 15 (4): 435–443. doi:10.1016/j.euroneuro.2005.04.006. PMID 15925492. S2CID 14905286.
Juliano, Laura M.; Griffiths, Roland R. (2004년 10월 1일). “A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features”. 《Psychopharmacology》 176 (1): 1–29. doi:10.1007/s00213-004-2000-x. PMID 15448977. S2CID 5572188.

snu.ac.kr

hosting03.snu.ac.kr

“서울대학교 임상ㆍ상담 심리학 연구실”. 2020년 8월 6일에 확인함.

web.archive.org

“Anxiety Disorders”. 《NIMH》. March 2016. 29 September 2016에 원본 문서에서 보존된 문서. 1 October 2016에 확인함.
Cloos JM (January 2005). “The treatment of panic disorder”. 《Current Opinion in Psychiatry》 18 (1): 45–50. PMID 16639183. 4 April 2011에 원본 문서에서 보존된 문서.
“Panic Disorder”. National Institute of Mental Health. 2006년 4월 28일에 원본 문서에서 보존된 문서. 2006년 5월 12일에 확인함.
“Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder” (PDF). National Collaborating Centre for Primary Care. 2004. 19 February 2009에 원본 문서 (PDF)에서 보존된 문서. 16 June 2009에 확인함.

worldcat.org

School Of Health Related Research (Scharr), University of Sheffield (2004). 《Clinical Guidelines for the Management of Anxiety: Management of Anxiety》. National Institute for Health and Clinical Excellence: Guidance. National Collaborating Centre for Primary Care. OCLC 708544131. PMID 20945576.